Sabra Health Care REIT, Inc. reported $860M of revenue over the trailing twelve months, +17% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $860M (to Q2 2026). Net income: $65M, trailing twelve months to Q2 2026. Free cash flow: −$313M, trailing twelve months to Q2 2026. EPS: $0.26, trailing twelve months to Q2 2026.

SBRASabra Health Care REIT, Inc.

Real Estate

$18.97+6.1% 1Y

$18.97

$16.4752 weeks$22.40

SBRA as reported

Sabra Health Care REIT, Inc. reported $860M of revenue over the trailing twelve months, +17% on the year before. 10 reported series are charted on this page, each one as filed.

$860M

Revenue, trailing twelve months · to Q2 2026 · +17% against the twelve months before

Net income: $65M
Net income · −64% year on year · trailing twelve months to Q2 2026
Free cash flow: −$313M
Free cash flow · −276% year on year · trailing twelve months to Q2 2026
EPS: $0.26
EPS · −66% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for SBRA, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$860M	+17%	Q2 2026
Net income	$65M	−64%	Q2 2026
EPS	$0.26	−66%	Q2 2026
Operating margin	92%	n/a	Q4 2018 · 30 quarters behind
Net margin	8.1%	n/a	Q2 2026
ROE	4.9%	n/a	Q2 2026
ROA	2.5%	n/a	Q2 2026
ROIC	6.7%	n/a	Q4 2018 · 30 quarters behind
Free cash flow	−$313M	−276%	Q2 2026
P/E	73.0	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.